TRCT
TELA icon

Tower Research Capital (TRC)’s TELA Bio TELA Stock Holding History

Tower Research Capital (TRC)’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548 Buy
+884
New +$768 ﹤0.01% 4842
2025
Q1 		– Sell
-923
Closed -$2.79K – 5777
2024
Q4 		$2.79K Sell
923
-794
-46% -$2.23K ﹤0.01% 4773
2024
Q3 		$4.34K Sell
1,717
-6,000
-78% -$21.3K ﹤0.01% 4578
2024
Q2 		$36.3K Buy
7,717
+5,981
+345% +$31.5K ﹤0.01% 3345
2024
Q1 		$9.84K Sell
1,736
-43
-2% -$284 ﹤0.01% 3782
2023
Q4 		$11.8K Sell
1,779
-398
-18% -$2.3K ﹤0.01% 4101
2023
Q3 		$17.4K Buy
2,177
+1,822
+513% +$16.9K ﹤0.01% 3503
2023
Q2 		$3.6K Sell
355
-143
-29% -$1.46K ﹤0.01% 5045
2023
Q1 		$5K Sell
498
-854
-63% -$9.42K ﹤0.01% 4993
2022
Q4 		$16K Sell
1,352
-2,010
-60% -$18K ﹤0.01% 3374
2022
Q3 		$29K Sell
3,362
-7,159
-68% -$59.4K ﹤0.01% 3639
2022
Q2 		$74K Buy
10,521
+9,331
+784% +$77.5K ﹤0.01% 2528
2022
Q1 		$14K Buy
1,190
+677
+132% +$8.2K ﹤0.01% 3925
2021
Q4 		$7K Buy
+513
New +$6.5K ﹤0.01% 4948
2021
Q3 		– Sell
-1,083
Closed -$17K – 6165
2021
Q2 		$17K Buy
1,083
+530
+96% +$7.26K ﹤0.01% 4052
2021
Q1 		$8K Sell
553
-827
-60% -$12.5K ﹤0.01% 4486
2020
Q4 		$21K Sell
1,380
-3,830
-74% -$62.2K ﹤0.01% 3848
2020
Q3 		$86K Buy
5,210
+3,810
+272% +$53.5K ﹤0.01% 3259
2020
Q2 		$18K Sell
1,400
-1,568
-53% -$20.6K ﹤0.01% 3742
2020
Q1 		$23K Buy
+2,968
New +$40.1K ﹤0.01% 1647

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Tower Research Capital (TRC)'s TELA Position: Q1 2026 in Review

Tower Research Capital (TRC) opened a new position in TELA Bio (TELA) in Q1 2026: 884 shares worth $548. The stake represents ﹤0.01% of the portfolio and ranks #4842 among its holdings. This is a return to the name: Tower Research Capital (TRC) previously reported a position in TELA as recently as Q4 2024.

Tower Research Capital (TRC) first reported a position in TELA in Q1 2020 and has held it in 20 quarters since. The position peaked at $86K in Q3 2020. 36 funds tracked by Wall St. Rank hold TELA as of Q1 2026.

  • Tower Research Capital (TRC) held 884 shares of TELA Bio worth $548 as of Q1 2026.
  • TELA Bio was a new Tower Research Capital (TRC) position in Q1 2026.
  • TELA Bio made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #4842 holding.
  • Tower Research Capital (TRC) first reported a position in TELA Bio in Q1 2020 and has held it in 20 quarters since.
  • Tower Research Capital (TRC)'s TELA Bio position peaked at $86K in Q3 2020.
  • 36 funds tracked by Wall St. Rank held TELA Bio as of Q1 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.